Stock search

Ticker or company name

Albemarle Corporation

ALB · NYSE · Chemicals

$88,16Down −5,37 (−5,74%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$11,0 bn
Div. yield
1,2%
Year to date
−33,9%
52 weeks: $89,77$221,00

Ratio score

94/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

8 ✓ · 1 — · 0 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM16,222,431,6
Forward P/E8,8—17,7
PEGn/a—3,3
P/S1,82,42,2
EV/EBITDA8,419,822,4
P/FCF7,6—27,5
P/B1,01,83,2

Industry median — across 9 profitable companies in “Chemicals” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 27 analysts

Buy
19
Hold
8
Sell
0

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20262,562,58Up +0,6%
Q2 20263,273,75Up +14,7%
Q1 20261,112,95Up +166,8%
Q4 2025−0,41−0,53Down −28,5%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue1,55 bn1,74 bn1,43 bn1,43 bn1,31 bn1,33 bn1,08 bn1,23 bn1,35 bn1,43 bn1,36 bn2,36 bn
EPS2,153,522,34−3,88−1,72−0,160,000,29−9,45−1,96−0,08−5,24
Margin19,1%27,5%22,3%−29,0%−12,3%1,7%3,8%6,1%−78,9%−13,2%0,2%−26,2%
FCF325 m638 m248 m233 m223 m−127 m363 m−355 m−62,6 m−84,7 m−481 m−782 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $7,35 m.

NameAmountSharesPrice
masters j kent15 May 2026 · sale$129 164700$184,52
masters j kent15 May 2026 · sale$2,18 m11 867$183,87
masters j kent15 May 2026 · sale$700 6173 826$183,12
masters j kent10 Mar 2026 · sale$171 133996$171,82
masters j kent10 Mar 2026 · sale$923 0035 392$171,18
masters j kent10 Mar 2026 · sale$918 5535 395$170,26
norris eric20 Feb 2026 · sale$941 7415 692$165,45
anderson melissa h.13 Feb 2026 · sale$1,38 m8 454$163,71

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Chemicals
Exchange
NYSE
Country
US
IPO date
22 Feb 1994

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
MOSMosaic Company (The)$21,2322would not consider—0,0%−9,4%
CFCF Industries$119,8589would consider8,4+17,9%32,2%
IFFInternational Flavors & Fragrances$79,9964would watch103,2−16,7%—
LYBLyondellBasell$61,6775would watch16,0−1,8%4,1%
DOWDow Inc.$31,96no score———
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.